Skip to main content

Find Clinical Trials

Home
Conditions
Proteostasis Deficiencies

Clinical trial condition

Proteostasis Deficiencies

Explore clinical trials studying Proteostasis Deficiencies. Study availability and eligibility vary by location and protocol.

1,351 public trials 352 recruiting studies

Refine in advanced search Browse all conditions

Proteostasis Deficiencies trial results

Completed

Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients

NCT03280056

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: University of California Irvine Alpha Stem Cell Clinic Irvine, California, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

California Pacific Medical Center San Francisco, California, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Perampanel Single Ascending Dose Transcranial Magnetic Stimulation Biomarker Study in Amyotrophic Lateral Sclerosis

NCT03793868

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Mayo Clinic Jacksonville, Florida, United States

View Trial Details

Completed

Care Ecosystem: Navigating Patients and Families Through Stages of Care

NCT02213458

Conditions: Alzheimer Disease, Arterial Occlusive Diseases, Arteriosclerosis, +30 more
Locations: University of California, San Francisco San Francisco, California, United States

University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)

NCT00876772

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Anorexia, +20 more
Locations: Charité - Universitätsmedizin, Berlin, Germany Berlin, Germany

View Trial Details

Completed

Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral Sclerosis

NCT01277315

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +10 more
Locations: Charité University Hospital Berlin, Germany

View Trial Details

Completed

Group-Based Telehealth Music Therapy Intervention for Patients With Dementia: A Pilot Study

NCT05508646

Conditions: Alzheimer Disease, Basal Ganglia Diseases, Behavior, +19 more
Locations: Maya Lichtenstein Wilkes-Barre, Pennsylvania, United States

View Trial Details

Completed

Enoxacin for Amyotrophic Lateral Sclerosis (ALS)

NCT04840823

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Montreal Neurological Institute-Hospital Montreal, Quebec, Canada

View Trial Details

Completed

Study of ALS Reversals 2: Genetic Analyses

NCT03464903

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +10 more
Locations: Duke ALS Clinic / DUSOM Dept of Neurology / DUHS Durham, North Carolina, United States

View Trial Details

Completed

HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

NCT02437110

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Infections, +10 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Study of Structural and Functional Brain Connectivity Changes in ALS (CoALS-II)

NCT05404867

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details